ArticleTransplantation and cellular therapy2022

Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma.

Audrey M Sigmund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.